HK Stock MarketDetailed Quotes

SKB BIO (06990)

Watchlist
  • 490.200
  • -5.400-1.09%
15min DelayNot Open Sep 22 16:07 CST
117.17BMarket Cap673.35P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SKB BIO (06990) Revenue Breakdown Overview

By Business/Source

Currency:CNY
2026/H1
Stock NameRevenueRatio
Drug sales income657.04M67.16%
许可及合作协议收入314.52M32.15%
提供研发服务收入6.78M0.69%

By Product

Currency:CNY
2026/H1
Stock NameRevenueRatio
Drug sales income657.04M67.16%
许可及合作协议收入314.52M32.15%
提供研发服务收入6.78M0.69%

By Country/Region

Currency:CNY
2026/H1
Stock NameRevenueRatio
中国(居住地)663.82M67.85%
United States of America283.4M28.97%
Switzerland30.48M3.12%
Other643K0.07%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +13.92%
Sample Name
Sample Code
 +7.78%
Sample Name
Sample Code
 +0.34%
4
SINO OIL & GAS
00702
0.00%
5
CNOOC
00883
-2.07%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +27.04%
Sample Name
Sample Code
 +24.41%
Sample Name
Sample Code
 +20.35%
4
China Great Wall Technology Group
000066
+12.95%
5
Lotus Holdings
600186
+11.95%
View More
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -